85 sources for “Garry P. Nolan”

FDA contract listing — selected Stanford award 75F40120C00176

U.S. Food and Drug Administration. fda.gov.

An FDA contract listing names Stanford University for 75F40120C00176, independently of the MaxFuse acknowledgement. The requirement concerns coronavirus research. Its wording differs from a later FDA presentation using the same identifier; the amendment or naming history remains unresolved. This supports a public institutional funding link, without establishing Nolan as the named principal investigator or a classified programme.